Amyloid β-peptide inhibits Na+-dependent glutamate uptake

Life Sciences

Volumn 65, Issue 18-19, 1999, Pages 1977-1981

  Lauderback, Christopher M ^a   Harris White, Marni E ^a   Wang, Yaning ^a   Pedigo Jr , Norman W ^a   Carney, John M ^b,c   Butterfield, D Allan ^a,b  

^a Dept Chem and Ctr Membrane Sci ^*  (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c EVOTEC AG   (Germany)

Author keywords

Amyloid; Excitotoxicity; Free radicals; Glutamate uptake

Indexed keywords

AMYLOID BETA PROTEIN; FREE RADICAL; GLUTAMIC ACID; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; CALCIUM HOMEOSTASIS; CONFERENCE PAPER; DRUG INHIBITION; HUMAN; LIPID PEROXIDATION; NERVE CELL DEGENERATION; NEUROTOXICITY; NEUROTRANSMITTER UPTAKE; OXIDATIVE STRESS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ASTROCYTES; GLUTAMIC ACID; HUMANS; SODIUM;

EID: 0033213296     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00459-2     Document Type: Conference Paper

References (44)

1. DW Choi Science 258 241-243 (1992).
2. S.M. Rothman and J.W. Olney Trends in Neurosci. 10 299-302 (1987).
3. B. Meldrum and J. Garthwaite Trends in Pharmacol.Sci. 11 379-386 (1990).
4. M.P. Mattson, K. Furukawa, A.J. Bruce, R.J. Mark, and E. Blanc in Molecular Models of Dementia (W. Wasco and R.E. Tanzi, eds.) Humana Press, Totowa, NJ pp. 103-143 (1997).
5. M. Lafanz-Cazal, S. Pietri, M. Culcasi, and J. Boekaert Nature 364 535-537 (1993).
6. B. Hammer, W.D. Parker, and J.P. Bennett Neuroreport 5 72-74 (1993).
7. P.G. Gunasekar, A.G. Kanthasamy, J.L. Borowitz, and G.E. Isom J. Neurochem. 65 2016-2021 (1995).
8. E. Lancelot, J. Callebert, M. Plotkine, and R.G. Boulu Neuroreport 6 1033-1036 (1995).
9. J.B. Schulz, D.R. Henshaw, D. Siwek, B.G. Jenkins, R.J. Ferrante, P.B. Cipolloni, N.W.Kowall, B.R. Rosen, and M.F. Beal J. Neurochem. 64 2239-2247 (1995).
10. E. Lancelot, L. Lecanu, M-L. Reuaud, R.G. Boulu, M. Plotkine, and J. Callebert Neurosci. Lett. 242 131-134 (1998).
11. R.M. Clark and G.G.S. Collins J. Physiol. (London) 262 384-400 (1976).
12. R.W. Baughman and C.D.Gilbert J. Neurosci. 1 427-439 (1981).
13. W.F. White, J.V. Nadler, A. Hamberger, C.W. Cotman, and J.T. Cummins Nature 270 356-367 (1977).
14. T.P. Hicks and R.C.A. Geddes Can. J. Physiol. Pharmacol. 59 893-896 (1981).
15. R.C.A. Pearson, M.M. Esiri, R.W. Hiorns, G.K. Wilcock, and T.P.S. Powell Proc. Natl. Acad. Sci. USA 82 4531-4534 (1985).
16. J. Rogers and J.H. Morrison J. Neurosci. 5 2801-2808 (1985).
17. M.P. Mattson, B. Cheng, D. Davis, K. Bryant, I. Leiberburg, and R.E. Rydel J. Neurosci. 12 376-389 (1992).
18. J-Y. Koh, Y.L. Yang and C.W. Cotman Brain Res. 533 315-320 (1990).
19. R.J. Mark, K. Hensley, D.A. Butterfield and M.P.Mattson J. Neurosci. 15 6239-6249 (1995).
20. D.J. Selkoe J. Neuropathol. Exp. Neurol. 53 438-447 (1994).
21. W.R. Markesbery Free Rad. Biol. Med. 23 134-147 (1997).
22. D.A. Butterfield Chem. Res. Toxicol. 10 495-506 (1997).
23. J.D. Rothstein, M. Dykes-Hoberg, C.A. Pardo, L.A. Bristol, L. Jin, R.W. Kunel, M.A. Hediger, Y. Wang, J.P. Schielke, and D.F. Welty Neuron 16 675-686 (1996).
24. P. Rosenberg and E. Aizenman Neurosci. Lett. 103 162-168 (1989).
25. A. Volterra, D. Trotti, C. Tromba, S. Floridi, and G. Racagin J. Neurosci. 14 2924-2932 (1994).
26. M.E. Harris, Y. Wang, N.W. Pedigo, Jr., K. Hensley, D.A. Butterfield, and J.M. Carney J. Neurochem. 67 277-286 (1996).
27. A. Parpura-Gill, D. Beitz, and E. Vemura Brain Res. 754 65-71 (1997).
28. M.E. Harris, J.M. Carney, P.S. Cole, K. Hensley, B.J. Howard, L. Martin, P. Bummer, Y. Wang, N.W. Pedigo, Jr., and D.A. Butterfield Neuroreport 6 1875-1879 (1995).
29. K. Hensley, J.M. Carney, M.P. Mattson, M. Aksenova, M.E. Harris, J.F. Wu, R.A. Floyd, and D.A. Butterfield Proc. Natl. Acad. Sci. USA 91 3270-3274 (1994).
30. M.Y. Aksenov, M.V.Aksenova, M.E. Harris, K. Hensley, D.A. Butterfield, and J.M. Carney J. Neurochem. 65 1899-1902 (1995).
31. J.N. Keller, Z. Pang, J.W. Geddes, J.G. Begley, A. Germeyer, G. Waeg, and M.P. Mattson J. Neurochem. 69 273-284 (1997).
32. D.A. Butterfield, K. Hensley, M.E. Harris, M.P. Mattson and J.M. Carney Biochem. Biophys. Res. Comm. 200 710-715 (1994)
33. T. Koppal, R. Subramaniam, J. Drake, M.R. Prasad, H. Dhillon, and D.A. Butterfield Brain Res. 786 270-273 (1998).
34. R.J. Mark, M.A. Lovell, W.R. Markesbery, K. Uchida, and M.P. Mattson J. Neurochem. 68 255-264 (1997).
35. D.A. Butterfield and E.R. Stadtman in Advances in Cell Aging and Gerontology 2 161-191 (1997).
36. J.N. Keller, R.J. Mark, A.J. Bruce, E. Blanc, J.D. Rothstein, K. Uchida, G. Waeg, and M.P. Mattson Neurosci. 80 685-696 (1997).
37. E. Blanc, J.N. Keller, S. Fernandez, and M.P. Mattson Glia 22 149-60 (1998).
38. J.E. Springer, R.D. Azbill, R.J. Mark, J.G. Begley, G. Waeg, and M.P. Mattson J. Neurochem. 68 2469-76 (1997).
39. E.R. Stadtman Science 257 1220-1224 (1992).
40. R. Subramaniam, F. Roediger, B. Jordan, M.P. Mattson, J.N. Keller, G. Waeg, and D.A. Butterfield J. Neurochem. 69 1161-1169 (1997).
41. R. Maki, M.B. Robinson, and M.A. Dicter J. Neurosci. 14 6754-6762 (1994).
42. G. Tong and C.E. Jahr Neuron 13 1195-1203 (1993).
43. J. Busciglio, J. Yeh, and B.A. Yankner J. Neurochem. 61 1565-1568 (1993).
44. E. Masliah, M. Alford, D. Salman, R. Deteresa, J. M. Mallory, and L. Hansen Ann. Neurol. 40 759-766 (1997).